Related references
Note: Only part of the references are listed.Dexamethasone in Hospitalized Patients with Covid-19
Peter Horby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial
Oriol Mitja et al.
CLINICAL INFECTIOUS DISEASES (2021)
The broad spectrum antiviral ivermectin targets the host nuclear transport importin alpha/beta 1 heterodimer
Sundy N. Y. Yang et al.
ANTIVIRAL RESEARCH (2020)
Emergency management for preventing and controlling nosocomial infection of the 2019 novel coronavirus: implications for the dermatology department
J. Tao et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Yu Chen et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Clark D. Russell et al.
LANCET (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
Abdo A. Elfiky
LIFE SCIENCES (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Coronavirus puts drug repurposing on the fast track
Charlotte Harrison
NATURE BIOTECHNOLOGY (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Two regimens of dexamethasone versus prednisolone for acute exacerbations in asthmatic Egyptian children
Dalia A. Elkharwili et al.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2020)
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Emmie de Wit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Canrong Wu et al.
ACTA PHARMACEUTICA SINICA B (2020)
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study
Lei Pan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma
Eric Salazar et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
Stephen A. Lauer et al.
ANNALS OF INTERNAL MEDICINE (2020)
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Vanessa Monteil et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
Wanbo Tai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells
Yueping Liu et al.
CLINICAL INFECTIOUS DISEASES (2020)
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Zhongliang Wang et al.
CLINICAL INFECTIOUS DISEASES (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study
Andrea Giacomelli et al.
CLINICAL INFECTIOUS DISEASES (2020)
Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak
Tao Zhang et al.
CURRENT BIOLOGY (2020)
Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection
Dan Yan et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak
Liangjun Chen et al.
EMERGING MICROBES & INFECTIONS (2020)
Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
Daniel E. Freedberg et al.
GASTROENTEROLOGY (2020)
A Review of Coronavirus Disease-2019 (COVID-19)
Tanu Singhal
INDIAN JOURNAL OF PEDIATRICS (2020)
Novel coronavirus: From discovery to clinical diagnostics
Tung Phan
INFECTION GENETICS AND EVOLUTION (2020)
Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence
Lisheng Wang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Teicoplanin: an alternative drug for the treatment of COVID-19?
Sophie Alexandra Baron et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
The convalescent sera option for containing COVID-19
Arturo Casadevall et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
Shutoku Matsuyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
Lisi Deng et al.
JOURNAL OF INFECTION (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
Meng Yuan et al.
SCIENCE (2020)
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Tocilizumab treatment in COVID-19: A single center experience
Pan Luo et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China
Qiang Ding et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Jianjun Gao et al.
BIOSCIENCE TRENDS (2020)
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment
Zhenwei Wang et al.
BIOSCIENCE TRENDS (2020)
Cutaneous manifestations in COVID-19: a first perspective
S. Recalcati
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
Kuldeep Dhama et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Developing antibody tests for SARS-CoV-2
Anna Petherick
LANCET (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung et al.
LANCET (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses
Chang Kyung Kang et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Drug researchers pursue new lines of attack against COVID-19
Charlotte Harrison
NATURE BIOTECHNOLOGY (2020)
The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro
Xi Wang et al.
CELL DISCOVERY (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin
Ehud Chorin et al.
NATURE MEDICINE (2020)
Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
Erin K. McCreary et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
Qingxian Cai et al.
ENGINEERING (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Joshua Geleris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals
Chunguang Yang et al.
FRONTIERS IN PUBLIC HEALTH (2020)
Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission-A Preliminary Report of a Retrospective Cohort Study
Jin-nong Zhang et al.
CURRENT MEDICAL SCIENCE (2020)
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 A Randomized Trial
Caleb P. Skipper et al.
ANNALS OF INTERNAL MEDICINE (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
Ka-Tim Choy et al.
ANTIVIRAL RESEARCH (2020)
Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series
Tobias Janowitz et al.
GUT (2020)
A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
Colin D. Funk et al.
FRONTIERS IN PHARMACOLOGY (2020)
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
Samia Arshad et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Severe COVID-19 infection in a patient with multiple sclerosis treated with fi ngolimod
Christian Foerch et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
Michael J. Joyner et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
Mayla Gabriela Silva Borba et al.
JAMA NETWORK OPEN (2020)
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 The GRECCO-19 Randomized Clinical Trial
Spyridon G. Deftereos et al.
JAMA NETWORK OPEN (2020)
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
Abdo A. Elfiky
LIFE SCIENCES (2020)
In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
Julien Andreani et al.
MICROBIAL PATHOGENESIS (2020)
Inflammation suppression by dexamethasone via inhibition of CD147-mediated NF-κB pathway in collagen-induced arthritis rats
Qishan Wang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)
The effect of large-scale anti-contagion policies on the COVID-19 pandemic
Solomon Hsiang et al.
NATURE (2020)
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
Brandi N. Williamson et al.
NATURE (2020)
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial
Yueping Li et al.
MED (2020)
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19
Joseph Magagnoli et al.
MED (2020)
Tocilizumab for treatment of patients with severe COVID-19: A retrospective cohort study
Tariq Kewan et al.
ECLINICALMEDICINE (2020)
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Giovanni Guaraldi et al.
LANCET RHEUMATOLOGY (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab
Xuhan Zhang et al.
BLOOD ADVANCES (2020)
Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence
Beth Russell et al.
ECANCERMEDICALSCIENCE (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China (vol 395, pg 497, 2020)
C. Huang et al.
LANCET (2020)
Discovering drugs to treat coronavirus disease 2019 (COVID-19)
Liying Dong et al.
DRUG DISCOVERIES AND THERAPEUTICS (2020)
Clinical trials on drug repositioning for COVID-19 treatment
Sandro G. Viveiros Rosa et al.
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH (2020)
Influenza virus polymerase inhibitors in clinical development
Frederick G. Hayden et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2019)
Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge
Michael K. Lo et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
Egor P. Tchesnokov et al.
VIRUSES-BASEL (2019)
The Role of Interleukin 6 During Viral Infections
Lauro Velazquez-Salinas et al.
FRONTIERS IN MICROBIOLOGY (2019)
Inhibitors of nuclear transport
David A. Jans et al.
CURRENT OPINION IN CELL BIOLOGY (2019)
Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A(H1N1)pdm09 virus infection by interfering with virus internalization process
Dat Huu Tran et al.
JOURNAL OF ANTIBIOTICS (2019)
The broad-spectrum antiviral drug arbidol inhibits foot-and-mouth disease virus genome replication
Morgan R. Herod et al.
JOURNAL OF GENERAL VIROLOGY (2019)
Azithromycin Protects against Zika Virus Infection by Upregulating Virus-Induced Type I and III Interferon Responses
Chunfeng Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Chloroquine inhibits endosomal viral RNA release and autophagy-dependent viral replication and effectively prevents maternal to fetal transmission of Zika virus
Shengnan Zhang et al.
ANTIVIRAL RESEARCH (2019)
The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection
George R. Painter et al.
ANTIVIRAL RESEARCH (2019)
Small-Molecule Antiviral β-D-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance
Maria L. Agostini et al.
JOURNAL OF VIROLOGY (2019)
Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia
Mart Toots et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Fingolimod retains cytolytic T cells and limits T follicular helper cell infection in lymphoid sites of SIV persistence
Maria Pino et al.
PLOS PATHOGENS (2019)
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Sabue Mulangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus
Luke D. Jasenosky et al.
ISCIENCE (2019)
The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis
Yue-Nan Ni et al.
CRITICAL CARE (2019)
Combined Intravitreal Bevacizumab And Dexamethasone In Bilateral Lupus Retinopathy
Ruchi Shrestha et al.
INTERNATIONAL MEDICAL CASE REPORTS JOURNAL (2019)
Triazavirine supramolecular complexes as modifiers of the peptide oligomeric structure
Alexey V. Shvetsov et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2018)
β-D-N4-Hydroxycytidine Is a Potent Anti-alphavirus Compound That Induces a High Level of Mutations in the Viral Genome
Nadya Urakova et al.
JOURNAL OF VIROLOGY (2018)
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
Yaseen M. Arabi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses
Jeong-Joong Yoon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience
Jae-Hoon Ko et al.
ANTIVIRAL THERAPY (2018)
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors)
G. Redelman-Sidi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
Waleed H. Mahallawi et al.
CYTOKINE (2018)
Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses
Jan Haviernik et al.
VIRUSES-BASEL (2018)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques
Jeremie Guedj et al.
PLOS MEDICINE (2018)
Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration
Hideki Tani et al.
PLOS ONE (2018)
Use of Favipiravir to Treat Lassa Virus Infection in Macaques
Kyle Rosenke et al.
EMERGING INFECTIOUS DISEASES (2018)
Fingolimod induces neuronal-specific gene expression with potential neuroprotective outcomes in maturing neuronal progenitor cells exposed to HIV
Rebeca Geffin et al.
JOURNAL OF NEUROVIROLOGY (2017)
Trial of Tocilizumab in Giant-Cell Arteritis
J. H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics
Alison E. Fohner et al.
PHARMACOGENETICS AND GENOMICS (2017)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Serum levels of interleukin-6 are linked to the severity of the disease caused by Andes Virus
Jenniffer Angulo et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort
Alessia Manni et al.
BRAIN AND BEHAVIOR (2017)
Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice
Chunfeng Li et al.
EBIOMEDICINE (2017)
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses
Michael K. Lo et al.
SCIENTIFIC REPORTS (2017)
Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis
Sergey A. Shiryaev et al.
SCIENTIFIC REPORTS (2017)
Characterization of β-D-N4-Hydroxycytidine as a Novel Inhibitor of Chikungunya Virus
Maryam Ehteshami et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases
Md Abdul Alim Al-Bari
PHARMACOLOGY RESEARCH & PERSPECTIVES (2017)
Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
Kentaro Yamada et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
Mizuki Yamamoto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Teicoplanin inhibits Ebola pseudovirus infection in cell culture
Yizhuo Wang et al.
ANTIVIRAL RESEARCH (2016)
Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Nan Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses
Eve-Isabelle Pecheur et al.
JOURNAL OF VIROLOGY (2016)
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K. Warren et al.
NATURE (2016)
Zika Virus in the Americas - Yet Another Arbovirus Threat
Anthony S. Fauci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Shuo Su et al.
TRENDS IN MICROBIOLOGY (2016)
Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models
Rodrigo Delvecchio et al.
VIRUSES-BASEL (2016)
Human coronavirus and severe acute respiratory infection in Southern Brazil
Hygor Trombetta et al.
PATHOGENS AND GLOBAL HEALTH (2016)
Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus
Jean-Francois Rossingol
JOURNAL OF INFECTION AND PUBLIC HEALTH (2016)
Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import
Veronika Goetz et al.
SCIENTIFIC REPORTS (2016)
Sphingosine-1-Phosphate Receptor Antagonism Enhances Proliferation and Migration of Engrafted Neural Progenitor Cells in a Model of Viral-Induced Demyelination
Caroline A. Blanc et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Protease inhibitors targeting coronavirus and filovirus entry
Yanchen Zhou et al.
ANTIVIRAL RESEARCH (2015)
A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs
Jianzhong Cao et al.
ANTIVIRAL RESEARCH (2015)
Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases
Md. Abdul Alim Al-Bari
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
Jasper Fuk-Woo Chan et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Hydroxychloroquine-Inhibited Dengue Virus Is Associated with Host Defense Machinery
Li-Fong Wang et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Reactivation of herpesvirus under fingolimod: A case of severe herpes simplex encephalitis
Nikolai Pfender et al.
NEUROLOGY (2015)
The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells
Mutsuo Yamaya et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2015)
Colchicine-Update on mechanisms of action and therapeutic uses
Ying Ying Leung et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Antiviral Activity of Chloroquine Against Dengue Virus Type 2 Replication in Aotus Monkeys
Kleber Juvenal Silva Farias et al.
VIRAL IMMUNOLOGY (2015)
Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication
Olivier Reynard et al.
VIRUSES-BASEL (2015)
Changing the face of hepatitis C management - the design and development of sofosbuvir
Bennett C. Noell et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Nucleocytoplasmic transport of nucleocapsid proteins of enveloped RNA viruses
Wahyu N. Wulan et al.
FRONTIERS IN MICROBIOLOGY (2015)
Evaluation of Ebola Virus Inhibitors for Drug Repurposing
Peter B. Madrid et al.
ACS INFECTIOUS DISEASES (2015)
Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells
Aline Schogler et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Favipiravir: A New Medication for the Ebola Virus Disease Pandemic
Takashi Nagata et al.
DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS (2015)
Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
Adriaan H. de Wilde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Nitazoxanide: A first-in-class broad-spectrum antiviral agent
Jean-Francois Rossignol
ANTIVIRAL RESEARCH (2014)
Arbidol as a broad-spectrum antiviral: An update
Julie Blaising et al.
ANTIVIRAL RESEARCH (2014)
Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: Synthesis and antiviral studies
Ilona Bereczki et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Mechanism of Action of Colchicine in the Treatment of Gout
Nicola Dalbeth et al.
CLINICAL THERAPEUTICS (2014)
From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
Rolf Hilgenfeld
FEBS JOURNAL (2014)
Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
Jaffar A. Al-Tawfiq et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
Identification of Diverse Alphacoronaviruses and Genomic Characterization of a Novel Severe Acute Respiratory Syndrome-Like Coronavirus from Bats in China
Biao He et al.
JOURNAL OF VIROLOGY (2014)
Nitazoxanide inhibits the replication of Japanese encephalitis virus in cultured cells and in a mouse model
Zixue Shi et al.
VIROLOGY JOURNAL (2014)
Mechanism of Action of T-705 Ribosyl Triphosphate against Influenza Virus RNA Polymerase
Hidehiro Sangawa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin
M. Y. F. Tay et al.
ANTIVIRAL RESEARCH (2013)
Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication
Lindsay Lundberg et al.
ANTIVIRAL RESEARCH (2013)
Thiazolides, a New Class of Antiviral Agents Effective against Rotavirus Infection, Target Viral Morphogenesis, Inhibiting Viroplasm Formation
Simone La Frazia et al.
JOURNAL OF VIROLOGY (2013)
The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies
Stefanie Gierer et al.
JOURNAL OF VIROLOGY (2013)
T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
Tatiana Baranovich et al.
JOURNAL OF VIROLOGY (2013)
Chloroquine Inhibits Dengue Virus Type 2 Replication in Vero Cells but Not in C6/36 Cells
Kleber Juvenal Silva Farias et al.
SCIENTIFIC WORLD JOURNAL (2013)
Inhibition of novel β coronavirus replication by a combination of interferon- α2b and ribavirin
Darryl Falzarano et al.
SCIENTIFIC REPORTS (2013)
Nuclear trafficking of proteins from RNA viruses: Potential target for antivirals?
Leon Caly et al.
ANTIVIRAL RESEARCH (2012)
Novel nucleoside analogue FNC is effective against both wild-type and lamivudine-resistant HBV clinical isolates
Yubing Zhou et al.
ANTIVIRAL THERAPY (2012)
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
Kylie M. Wagstaff et al.
BIOCHEMICAL JOURNAL (2012)
Effects of Hydroxychloroquine on Immune Activation and Disease Progression Among HIV-Infected Patients Not Receiving Antiretroviral Therapy A Randomized Controlled Trial
Nicholas I. Paton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Teicoplanin therapy leading to a significant decrease in viral load in a patient with chronic hepatitis C
Andreas Maieron et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug
Eloise Mastrangelo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Japanese Encephalitis Virus Enters Rat Neuroblastoma Cells via a pH-Dependent, Dynamin and Caveola-Mediated Endocytosis Pathway
Yong-Zhe Zhu et al.
JOURNAL OF VIROLOGY (2012)
Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavirus
Patrick C. Y. Woo et al.
JOURNAL OF VIROLOGY (2012)
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Ali Moh Zaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
An Analogue of the Antibiotic Teicoplanin Prevents Flavivirus Entry In Vitro
Tine De Burghgraeve et al.
PLOS ONE (2012)
Thymosin-alpha 1 (Zadaxin™) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria™) in hennodialyzed patients: A pilot study
G. Carraro et al.
VACCINE (2012)
Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience
James R. Smith et al.
ADVANCES IN THERAPY (2011)
FNC, a novel nucleoside analogue inhibits cell proliferation and tumor growth in a variety of human cancer cells
Qiang Wang et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics
Susan Obeid et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus
Raymund R. Razonable
MAYO CLINIC PROCEEDINGS (2011)
Azithromycin induces anti-viral responses in bronchial epithelial cells
V. Gielen et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma
Michele Maio et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults
Vianney Tricou et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice
Els Keyaerts et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Comparative Efficacy and Safety of Vancomycin versus Teicoplanin: Systematic Review and Meta-Analysis
Shuli Svetitsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV
Erik De Clercq
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
The spike protein of SARS-CoV - a target for vaccine and therapeutic development
Lanying Du et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites
Sandrine Belouzard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The pharmacokinetics and interactions of ivermectin in humans - A mini-review
Aranzazu Gonzalez Canga et al.
AAPS JOURNAL (2008)
Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: Involvement of p38 MAPK and ERK
Masakazu Kono et al.
ANTIVIRAL RESEARCH (2008)
Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication
Brent E. Korba et al.
ANTIVIRAL RESEARCH (2008)
Use of corticosteroids in treating infectious diseases
Steven McGee et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway
Hongliang Wang et al.
CELL RESEARCH (2008)
Respiratory viruses other than influenza virus: Impact and therapeutic advances
W. Garrett Nichols et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
The M, E, and N Structural Proteins of the Severe Acute Respiratory Syndrome Coronavirus Are Required for Efficient Assembly, Trafficking, and Release of Virus-Like Particles
Y. L. Siu et al.
JOURNAL OF VIROLOGY (2008)
Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic Reticulum/Golgi membrane
Matthew Frieman et al.
JOURNAL OF VIROLOGY (2007)
Chloroquine is effective against influenza A virus in vitro but not in vivo
David J. Vigerust et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2007)
A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis
Howard M. Corneli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Immunoregulation of thymosin alpha 1 treatment of cytomegalovirus infection accompanied with acute respiratory distress syndrome after renal transplantation
S. -M. Ji et al.
TRANSPLANTATION PROCEEDINGS (2007)
Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics
Jan Balzarini et al.
ANTIVIRAL RESEARCH (2006)
Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin
Dale L. Barnard et al.
ANTIVIRAL RESEARCH (2006)
Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?
A. R. L. Medford et al.
THORAX (2006)
Inhibition of human coronavirus NL63 infection at early stages of the replication cycle
Krzysztof Pyrc et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
In vitro inhibition of human influenza A virus replication by chloroquine
Eng Eong Ooi et al.
VIROLOGY JOURNAL (2006)
SARS: Systematic review of treatment effects
Lauren J. Stockman et al.
PLOS MEDICINE (2006)
Polycyclic peptide and glycopeptide antibiotics and their derivatives as inhibitors of HIV entry
Maria N. Preobrazhenskaya et al.
ANTIVIRAL RESEARCH (2006)
Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus
KA Timani et al.
VIRUS RESEARCH (2005)
A major determinant for membrane protein interaction localizes to the carboxy-terminal domain of the mouse coronavirus nucleocapsid protein
KR Hurst et al.
JOURNAL OF VIROLOGY (2005)
Drug therapy - Neuraminidase inhibitors for influenza
A Moscona
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
F Li et al.
SCIENCE (2005)
Intracellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein: Absence of nucleolar accumulation during infection and after expression as a recombinant protein in Vero cells
RRR Rowland et al.
JOURNAL OF VIROLOGY (2005)
The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial
S Iino et al.
JOURNAL OF VIRAL HEPATITIS (2005)
Nitazoxanide: A new thiazolide antiparasitic agent
LM Fox et al.
CLINICAL INFECTIOUS DISEASES (2005)
Programmed ribosomal frameshifting in decoding the SARS-CoV genome
PV Baranov et al.
VIROLOGY (2005)
An interferon-γ-related cytokine storm in SARS patients
KJ Huang et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
CK Wong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs
ELC Tan et al.
EMERGING INFECTIOUS DISEASES (2004)
Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice
K Subbarao et al.
JOURNAL OF VIROLOGY (2004)
Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors
SW Liu et al.
LANCET (2004)
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
CM Chu et al.
THORAX (2004)
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
F Chen et al.
JOURNAL OF CLINICAL VIROLOGY (2004)
Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity
F Romanelli et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
pH-dependent entry of Severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN
ZY Yang et al.
JOURNAL OF VIROLOGY (2004)
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
E Keyaerts et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak
JJY Sung et al.
THORAX (2004)
A pilot study of the safety and efficacy of thymosin α1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy
D Chadwick et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003
NS Zhong et al.
LANCET (2003)
Treatment of SARS with human interferons
J Cinatl et al.
LANCET (2003)
Lung pathology of fatal severe acute respiratory syndrome
JM Nicholls et al.
LANCET (2003)
Identification of severe acute respiratory syndrome in Canada
SM Poutanen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
C Drosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Ribonucleoside analogue that blocks replication of bovine viral diarrhea and hepatitis C viruses in culture
LJ Stuyver et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
In vitro effect of thymosin-α1 and interferon-α on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C
P Andreone et al.
JOURNAL OF VIRAL HEPATITIS (2001)
Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema
RJ Kaner et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2000)
Share Paper
